Related Experiment Video
Updated: May 7, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Inhibition of ADAMTS1 and ATP citrate lyase attenuates connexin-43 degradation and HFrEF
Yu-Ting Zheng1, Suresh C Tyagi1
1Department of Physiology, School of Medicine, University of Louisville, Louisville, KY 40202, USA.
Insights
Heart failure with reduced ejection fraction (HFrEF) involves connexin-43 (Cx43) degradation and mitochondrial issues. Inhibiting ADAMTS1 or ACYLi may offer therapeutic benefits for HFrEF.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- 56% of heart failure cases have unknown causes, with ADAMTS implicated.
- Connexin-43 (Cx43) degradation and blood-heart barrier leakage occur in heart failure with reduced ejection fraction (HFrEF).
- The role of mitochondrial ATP citrate lyase (ACYL) in HFrEF is unknown, though its inhibition causes HFpEF.
Purpose of the Study:
- To investigate the role of ADAMTS1 in Cx43 degradation and mitochondrial dysfunction during HFrEF.
- To explore the therapeutic potential of ADAMTS1 and ACYL inhibitors in HFrEF.
Main Methods:
- Created a mouse model of HFrEF using aorta-vena cava fistula (AVF).
- Administered ADAMTS1 inhibitor (epigallocatechin gallate) or ACYLi (hydroxycitric acid lactone) to mice.
- Assessed cardiac function via echocardiography and measured protein levels (Cx43, ADAMTS1, Drp1, ACYL) using Western blot and zymography.
Main Results:
- ADAMTS1 activation was observed during HFrEF.
- Increased Cx43 degradation and mitochondrial mitophagy (via Drp1 increase) were linked to HFrEF.
- Both ADAMTS1 and ACYL inhibitors showed potential therapeutic effects in systolic HFrEF.
Conclusions:
- ADAMTS1 activation contributes to Cx43 degradation and mitochondrial dysfunction in HFrEF.
- Inhibitors of ADAMTS1 and ACYL represent potential therapeutic strategies for HFrEF.
Abstract:
Human genome- and transcriptome-wide analyses revealed that 56% of heart failure cases have unknown causes. Interestingly, a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) is one of those causes. Previously, we have shown a robust increase in the degradation of a disintegrin and metalloproteinase (ADAM) and connexin-43 (Cx43) in human end-stage heart failure with reduced ejection fraction (HFrEF). We also observed Cx43 degradation and blood-heart barrier leakage during HFrEF in mice. Although Cx43 coordinates mitochondrial fusion-fission with myocyte contraction-relaxation, respectively, the mechanism is unclear. Interestingly, inhibition of mitochondrial ATP citrate lyase (ACYLi, a lipid-lowering agent) causes HFpEF, but its role in HFrEF is unknown. We hypothesize that during HFrEF, activation of ADAMTS1 degrades Cx43, causing dyssynchronous endothelial-myocyte-mitochondrial contraction coupling, as well as myocyte slippage during contraction and HFrEF. Because HFrEF is more prevalent in males than females, we created chronic cardiopulmonary volume overload by aorta-vena cava fistula (AVF) below the kidney in male wild-type (C57BL/6J) mice aged 12 weeks. By serial echocardiography, we observed HFrEF after 16 weeks. The ADAMTS1 inhibitor (epigallocatechin gallate) or ACYLi (hydroxycitric acid lactone) was administered in drinking water at the same time as AVF. Also, to assess interoceptive inhibition via Piezo channels, we ganglionally denervated the heart prior to AVF. By gel-specific substrate zymography, we measured NGAL, MMP2, MMP9, ADAMTS1, ADAMTS14, and TMPRSS2. The levels of Cx43, ADAMTS1, mitochondrial Drp1 (fission protein), and ACYL were measured by Western blot analysis. The results suggest that ADAMTS1 is activated during HFrEF. Connexin-43 degradation and mitochondrial mitophagy were increased by an increase in Drp1. The therapeutic effects of ADAMTS1 and ACYL inhibitors for systolic HFrEF are suggested.
Related Concept Videos
Feedback Inhibition
ATP Synthase: Mechanism
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure V: Medical Management

